Skip to main
NNOX

Nano-X Imaging (NNOX) Stock Forecast & Price Target

Nano-X Imaging (NNOX) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Nano X Imaging is experiencing improving top-line growth and expanding distribution partnerships, but this has yet to translate into significant revenue. Their management has acknowledged the need for additional financing to continue executing on their growth strategy. Moving forward, success will be reliant on the realization of anticipated catalysts such as new distribution agreements, initial system deployments, and evidence of utilization, all of which will be necessary to validate their commercial model and drive meaningful revenue growth.

Bears say

Nano X Imaging is focused on providing an integrated medical imaging platform and has signed on a partnership with Howard Medical to drive adoption in underserved settings and support a scalable rollout. With a capital-light commercial model and established relationships, the company aims to penetrate hospital networks and outpatient settings, but scaling may be a challenge due to bottlenecks in deployment and ongoing support. Furthermore, the company relies heavily on its Radiology Services segment for revenue, making its overall financials vulnerable to any disruptions in this area.

Nano-X Imaging (NNOX) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Nano-X Imaging (NNOX) Forecast

Analysts have given Nano-X Imaging (NNOX) a Buy based on their latest research and market trends.

According to 3 analysts, Nano-X Imaging (NNOX) has a Buy consensus rating as of Sep 22, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Nano-X Imaging (NNOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.